CCL20 expression has been described in a variety of human neoplasms, including colorectal, lung, pancreatic and breast human adenocarcinomas, malignant glioma, leukemia, lymphoma and melanoma However, the role of CCL20 in cancer development remains controversial. The gene discussed is CCL20; the disease is malignant glioma.